Drug Shortages

Below is a list of current and anticipated ophthalmic drug shortages gathered from Health Canada. Drugs that have been out of production or unavailable for more than 12 months are not included in this table.
The table is updated daily.

Last Updated: 2021-11-27 00:01:13

Drug Name Drug Status Last Updated DIN Type Anticipated Start Date Estimated End Date Actual Start Date Actual End Date Shortage Reason
VISUDYNE Marketed 2020-06-17 02242367 Shortage 2022-01-31 2020-08-01 Disruption of the manufacture of the drug.
CEQUA Approved 2021-03-08 02512629 Shortage 2021-12-15 2021-11-04 Delay in shipping of the drug.
DIOFLUOR STRIPS Marketed 2020-08-05 02160773 Shortage 2020-12-01 2022-01-07 2021-03-22 Shortage of an active ingredient.
ACT LATANOPROST/TIMOLOL Marketed 2021-09-09 02436256 Shortage 2021-08-27 Disruption of the manufacture of the drug.
APO-TIMOP Marketed 2018-03-08 00755834 Shortage 2021-11-15 2021-12-10 2021-10-27 Disruption of the manufacture of the drug.
ATROPINE Marketed 2019-04-06 02023695 Shortage 2020-11-01 Delay in shipping of the drug.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP Marketed 2021-07-08 02326663 Shortage 2021-12-15 2017-03-09 Disruption of the manufacture of the drug.
MINIMS ATROPINE SULPHATE Marketed 2020-12-09 02148358 Shortage 2021-11-19 2021-08-16 Other (Please describe in comments)
OCUFLOX Marketed 2020-04-03 02143291 Shortage 2022-09-30 2021-04-06 Disruption of the manufacture of the drug.
SANDOZ TRAVOPROST Marketed 2019-08-03 02413167 Shortage 2021-12-03 2021-11-15 Disruption of the manufacture of the drug.
VIROPTIC Marketed 2020-11-09 00687456 Shortage 2017-06-14 Shortage of an active ingredient.

- Minimize

+ Maximize

:
: